Related by context. All words. (Click for frequent words.) 76 League Against Rheumatism 67 Cardiology ESC 66 ECTRIMS 65 AASLD 64 Medical Oncology ESMO 64 ESMO 63 ISPOR 62 Respiratory Society 62 Rheumatology 62 ECCO ESMO 61 ICAAC IDSA 61 OARSI 60 EASD 60 EULAR Annual 60 EASL 60 EFNS 59 st Annual Meeting 59 Diabetes EASD 59 SABCS 59 UEGW 59 ICAAC 59 ASCO GI 58 American Thoracic Society 58 Gastrointestinal Cancer 58 Liver EASL 58 ECCMID 58 Pharmacoeconomics 58 AACR NCI EORTC 58 ASBMR 57 Digestive Disease Week DDW 57 ECNP 57 Clinical Microbiology 57 Gastrointestinal Cancers Symposium 57 Heart Failure Society 57 Cardiostim 57 Endocrine Society #st 57 Endocrine Society ENDO 56 AACR San Antonio 56 ISHLT 56 Digestive Disease Week 56 EORTC 56 ERA EDTA 56 Urology EAU 56 Late Breaker 56 Neuropathic Pain 56 #th Annual Interscience 56 ASH Annual Meeting 56 ACC AHA 56 Hematology ASH 56 ISTH 56 Association EHA 56 EuroPCR 55 Mineral Research ASBMR 55 RoACTEMRA 55 Hematology Meeting 55 European CanCer Organisation ECCO 55 ASCO Annual Meeting 55 Transcatheter Cardiovascular Therapeutics TCT 55 CTRC AACR San Antonio 55 AACR #st Annual Meeting 55 Hematology ASH Annual Meeting 55 CROI 55 Rheumatology EULAR 54 ASCO GU 54 oral FTY# 54 EORTC NCI AACR 54 Lung Transplantation 54 Society CTOS 54 Genitourinary Cancers Symposium 54 America HFSA 54 Multiple Sclerosis ECTRIMS 54 Cancers Symposium 54 Clinical Oncology ASCO 54 tocilizumab 54 EUROGIN 54 Hypertension ESH 54 Scientific Meeting 54 Pediatric Academic Societies PAS 54 Alzheimer Disease ICAD 54 teriflunomide 54 Neurology AAN 54 Clinical Oncology Annual Meeting 54 Infectious Diseases ECCMID 53 Cimzia ® certolizumab pegol 53 ADA Scientific Sessions 53 AHA Scientific Sessions 53 PROSTVAC TM 53 Neuro Oncology SNO 53 Transcatheter Cardiovascular Therapeutics 53 HFSA 53 Scientific Session 53 Hematology Annual Meeting 53 EADV 53 Diabetologia 53 #st Annual Meeting 53 International OARSI 53 Anesthesiologists ASA 53 Chicago Multidisciplinary Symposium 53 Antimicrobial Agents 53 ACR ARHP 53 Clinical Oncology ASCO Annual 53 REACH Registry 53 nd Annual Meeting 52 Arteriosclerosis Thrombosis 52 Endocrine Society #nd 52 ASCO 52 Gynecologic Cancer Society 52 Neurological Societies 52 oxycodone CR 52 EORTC NCI AACR Symposium 52 ARVO 52 Malignant Lymphoma 52 recurrent GBM 52 Clinical Oncology 52 Solid Tumors 52 Annual Scientific Sessions 52 Digestive Diseases Week 52 Clinical Oncology Gastrointestinal Cancers 52 Hematology 52 Interventional Radiology SIR 52 AACR #nd Annual Meeting 52 Radiology ECR 52 Headache Society 52 alvimopan 52 iSBTc 52 etanercept 51 morphometric vertebral fractures 51 Connective Tissue Oncology 51 Neuropsychopharmacology 51 J Clin Oncol 51 Clinical Practice Guideline 51 Rheumatology ACR 51 sipuleucel T 51 Ambrisentan 51 Cachexia 51 apremilast 51 EVEREST II 51 CombAT 51 Opportunistic Infections CROI 51 Inflammatory Bowel Diseases 51 RTOG 51 Cardiology 51 Rheumatoid Arthritis RA 51 atherothrombotic disease 51 ORAL Sync 51 Scientific Sessions 51 Breast Cancer Symposium 51 PreCISe 51 Cell Biology ASCB 51 San Antonio Breast Cancer 51 SYNTAX trial 51 Antiviral Therapy 51 adalimumab 51 Cardiology ESC Congress 51 orally inhaled migraine 51 Crohn Disease Activity 51 ACTEMRA 51 American Urological Association 51 Venereology EADV 51 ASCO Genitourinary Cancers Symposium 51 Etanercept 51 NAASO 51 abatacept 51 USpella 51 PsA 51 Chemotherapy ICAAC 51 Biological Therapy 51 ASGT 51 AACR 51 Percutaneous Cardiovascular Interventions 51 Pediatric Academic Societies 51 AUA Annual Meeting 51 rheumatoid arthritis RA 51 Vascular Biology ATVB 51 Systemic Sclerosis 51 CDAI 51 BoNTA 51 EMBLEM TM 51 Therapeutic Radiology 51 phase IIb study 50 Arterial Hypertension 50 #rd Annual CTRC 50 Hypertension ASH 50 Aggressive Reduction 50 Continence Society 50 ACTEMRA TM 50 valvular heart 50 Rheumatology ACR Annual 50 Abstract Number 50 ACR# [002] 50 Echocardiography ASE 50 Rheumatology Annual 50 acute myocardial infarction MI 50 clevidipine 50 Malignant Mesothelioma 50 Neurological Societies EFNS 50 ANN INTERN MED 50 Therapeutics TCT 50 Betaferon R 50 pramipexole 50 Selective Cardiac Myosin 50 Natalizumab 50 Cardiology Heart Failure 50 #mg BID [001] 50 HUPO 50 dyslipidaemia 50 #th Interscience Conference 50 Castration Resistant Prostate Cancer 50 HAQ DI 50 Molecular Targets 50 EORTC NCI 50 ASCO Breast Cancer 50 Durezol 50 Neurological Surgeons AANS 50 Belimumab 50 International Papillomavirus 50 tolvaptan 50 brivaracetam 50 Edge STudy 50 rheumatic diseases 50 Oral Fingolimod 50 polyarticular 50 Liver Diseases AASLD 50 Arch Intern Med 50 Fifth Decennial International 50 EXPAREL ™ 50 & OTO EXPO 50 Chronic Heart Failure 50 Systemic Lupus Erythematosus 50 Osteoarthritis 50 Environ Health Perspect 50 RAPAFLO R 50 RECIST Response Evaluation Criteria 50 LHON 50 ADHF 50 Nephrology Renal Week 50 EACTS 50 FOLPI 50 Bipolar Disorders 49 lacosamide 49 HCV Protease Inhibitor 49 juvenile idiopathic arthritis 49 Menopause Society NAMS 49 Endocrine Society 49 COPAXONE R 49 Response Evaluation Criteria 49 clinical pharmacology studies 49 Arch Neurol 49 Annual Transcatheter Cardiovascular 49 Relapsing Multiple Sclerosis 49 AA Amyloidosis 49 CLARITY study 49 Interventional Radiological Society 49 Outcomes Research ISPOR 49 Clinical Oncologists 49 TG MV 49 Embryology ESHRE 49 ACR# ACR# 49 Poster Discussion 49 SAEM Annual Meeting 49 thetreatment 49 adalimumab Humira 49 HYVET 49 Hematological 49 ESCRS 49 Neurological Surgeons 49 Interventions SCAI 49 ischemic cardiomyopathy 49 Traficet EN 49 European CanCer Organisation 49 Ankylosing Spondylitis 49 CIMZIA TM 49 EAACI 49 ALN TTR 49 ARCOXIA 49 Therapeutics TCT scientific 49 BOLDER II 49 Haemostasis ISTH 49 efficacy tolerability 49 prucalopride 49 sorafenib tablets 49 pulmonary arterial hypertension PAH 49 ProSavin 49 Experimental Biology EB 49 AACR IASLC Joint 49 American Geriatrics Society 49 Oral Presentation 49 AACR Frontiers 49 Poster Presentation 49 Allergology 49 Immunology Annual Meeting 49 Breaking Clinical Trials 49 Autoimmunity 49 Related Disorders ICAD 49 #nd Annual Meeting 49 AAPM 49 TLR antagonist 49 EchoCRT 49 HIF PHI 49 acute ischemic stroke 49 ATACAND 49 ESTRO 49 AAO HNSF Annual Meeting 49 aclidinium bromide 49 Severe Asthma 49 oral rivaroxaban 49 Heart Failure 49 BIO InvestorForum 49 Betaferon ® 49 ponatinib 49 ASCRS 49 tapentadol ER 49 Marrow Transplantation 49 APTIVUS R 49 oral diclofenac 49 MERLIN TIMI 49 Oncology ESTRO 49 Human Brain Mapping 49 Canaccord Adams Hepatitis C 48 Arch Surg 48 II Clinical Trial 48 Oncology ASTRO 48 DAS# CRP 48 CIMZIA TM certolizumab pegol 48 HORIZONS AMI 48 Ranolazine 48 Liver Disease AASLD 48 osteoarthritis OA 48 Liver Disease 48 American Psychosomatic Society 48 AASLD Meeting 48 rilonacept 48 PROactive Study 48 briakinumab 48 Autoimmune Diseases 48 icatibant 48 Clinical Efficacy 48 Breast Surgeons ASBS 48 Cardiology ACC 48 NCCTG N# 48 DDW 48 Thrombosis 48 periprocedural MI 48 trials RCTs 48 Heart Rhythm 48 radezolid 48 PROTECT II 48 HyQ 48 CTAP# Capsules 48 APPRAISE 48 PRECiSE 48 zonisamide SR 48 Diabetic Macular Edema 48 CIRSE 48 acute coronary syndromes ACS 48 Liver Diseases 48 evaluating tivozanib 48 CardioBip 48 CDAI score 48 abstracts summarizing 48 Epilepsy Society 48 SPIRIT IV 48 Vascular Annual Meeting 48 mg BID dose 48 Rheumatologists 48 ELACYT 48 ESHRE 48 INCB# [001] 48 Neurology Annual Meeting 48 Treatment Resistant 48 Major Depressive Disorder 48 methotrexate MTX 48 Clinical Trial Results 48 Cancer iSBTc 48 diabetic neuropathic pain 48 International Neuropsychological Society 48 ankylosing spondylitis AS 48 tanespimycin 48 mg QD 48 tolterodine ER 48 EFORT Congress 48 & Immunology AAAAI 48 mRCC 48 tasocitinib 48 Cardiac Techniques 48 Am J Epidemiol 48 Doxil ® 48 viral kinetics 48 clinically meaningful 48 Venereology 48 AIR2 Trial 48 adult chronic ITP 48 postmenopausal osteoporotic women 48 coinfected patients 48 ExTRACT TIMI 48 methotrexate monotherapy 48 atrasentan 48 Chronic Myeloid Leukemia 48 Abstract # 48 achieved ACR# 48 AAN Annual Meeting 48 HORIZONS AMI trial 48 Nephrol Dial Transplant 48 demonstrated clinically meaningful 48 paroxysmal AF 48 Eur Respir J 48 Pharmacotherapy 48 Safinamide 48 Eur J Endocrinol 48 stable angina 48 Fondaparinux 48 Endourology 48 Interscience Conference 48 tipranavir 48 Pirfenidone 48 Neck Cancer 48 IASLC 48 noninferiority 48 Abbott HUMIRA 48 mycophenolate mofetil 48 Selective Cardiac Myosin Activator 48 desvenlafaxine succinate 48 Teriflunomide 48 clinically meaningful improvements 48 Thoracic Oncology 48 Retina Specialists 48 viral kinetic 48 AAAAI 48 vidofludimus 48 canakinumab 48 bosentan 48 Medical Oncology 48 recurrent glioma 48 Subgroup Analysis 48 Controlled Release 47 AAPS Annual Meeting 47 biologic therapy 47 PERSEUS 47 IRX 2 47 ACZ# 47 atherothrombotic events 47 riociguat 47 Antiviral Activity 47 Primary endpoints 47 NATRECOR R 47 Peripheral Arterial Disease 47 J Urol 47 International Myeloma Workshop 47 MabCampath 47 teriparatide 47 Ann Oncol 47 transthyretin TTR mediated amyloidosis 47 Femara letrozole 47 ADAGIO study 47 ibandronate 47 DAS# [002] 47 PCWP 47 BHIVA 47 HeFH 47 Br J Cancer 47 Hematology ASH Meeting 47 Neck Surgery Foundation 47 Acute Coronary Syndromes 47 Am J Pathol 47 pazopanib 47 Prostate Cancer Symposium 47 ongoing Phase 1b 47 Panzem R 47 neurocognitive deficits 47 topical NSAIDs 47 knee osteoarthritis OA 47 prospective multicentre 47 COPD exacerbations 47 rotigotine 47 Thromboembolic 47 AACR Meeting 47 BRIM2 47 tolerability profiles 47 SA FC# 47 KRAS status 47 Therapeutic Radiation 47 AOFAS 47 Thrombolysis 47 TMC# C# 47 ACUITY trial 47 Movement Disorder 47 psoriatic arthritis PsA 47 pregabalin 47 Neurological Surgeons CNS 47 microalbuminuria 47 Dr. Gulfo 47 Benign Prostatic Hyperplasia 47 safinamide 47 Cardiovascular Anesthesiologists 47 Advanced Renal Cell 47 th Interscience Conference 47 seropositive patients 47 Oncologic Drugs Advisory 47 CTEPH 47 Atacand 47 AACR NCI EORTC Molecular 47 TMS Therapy 47 Clinical Endocrinologists AACE 47 Dyloject TM 47 CTI Nasdaq 47 TIMI Study Group 47 GOUT 47 Phase 1b trial 47 Radiation Oncology ASTRO 47 RAPTIVA 47 INCB# [003] 47 Paediatric Infectious Diseases 47 Safety Tolerability 47 Dendritic Cells 47 BPS IC 47 Pharmacodynamics 47 Cerebrovascular Diseases 47 galiximab 47 ACAAI 47 NeuroStar TMS Therapy 47 Cardiometabolic 47 Meta Analysis 47 VADT 47 Phase 2a trial 47 somatostatin analog 47 J. Mazzo Ph.D. 47 arthropathy 47 DAPT 47 Phase 2a clinical 47 sUA 47 pain palliation 47 mITT population 47 Symposium SABCS 47 AAPOS 47 FASEB J. 47 PTNS 47 CIMZIA ™ 47 Hypertension 47 Outpatient Setting 47 J Am Coll 47 SEROQUEL XR 47 entecavir 47 ELSO 47 6R BH4 47 Clinical Psychiatry 47 Hematological Malignancies 47 Adalimumab 47 Index CDAI 47 iclaprim 47 ENDO 47 Ophena TM 47 pharmacokinetic PK 47 ACR# responses 47 PROactive study 47 ON #.Na 47 carotid artery stenting CAS 47 Dose Escalation 47 AAO HNS 47 IBS C 47 NCCN guidelines 47 forodesine 47 ACR# response 47 ABRF 47 KRAS mutations occur 47 Phase III ALLEGRO 47 Immunology AAAAI 47 relapsed MM 47 PEARL HF 47 cinacalcet 47 Regional Anesthesia 47 Acute Stroke 47 BCIRG 47 RIO Lipids 47 bronchial hyperresponsiveness 47 CARE HF 47 N Engl J 47 Preclinical Data 47 Stent Thrombosis 47 Inhalation Solution 47 sustained virological response 47 corticosteroid dose 47 HAMD 47 aromatase inhibitors AIs 47 ACOMPLIA R 47 BIOCOM Investor Conference 46 Golimumab 46 MoxDuo TM IR 46 FDA Oncologic Drugs 46 OSAHS 46 PROVENGE sipuleucel T 46 Therapeutics Roundtable 46 ABCSG 46 baminercept 46 abdominal pain abdominal discomfort 46 placebo controlled clinical 46 virologic 46 HuMax EGFr 46 entitled Synergistic 46 Neuropsychologia 46 Prolongs Survival 46 Chronic Prostatitis 46 ASGCT 46 Hsp# Inhibitor 46 Annual ICAAC 46 Cethromycin 46 Psoriasis Area 46 Liver Meeting 46 Annual Interscience Conference 46 Severity Index PASI 46 Nephrology ASN Renal 46 INVEGA ® 46 Phase #/#a trial 46 meta regression 46 β blockers 46 liposome injection 46 TORISEL 46 recurrent glioblastoma multiforme 46 Brentuximab Vedotin SGN 46 BENICAR 46 Pharmacoepidemiology 46 J Clin Endocrinol Metab 46 Overactive Bladder 46 Targeted Therapies 46 relapsing multiple sclerosis 46 Intervention Effectiveness 46 Ocrelizumab 46 CUSTOM II 46 Recurrent Chest Wall 46 delafloxacin 46 Oligonucleotide Therapeutics Society 46 aldosterone antagonists 46 plus methotrexate 46 J Rheumatol 46 Osseointegration 46 Carfilzomib 46 nonvertebral fractures 46 DMARD 46 ARIXTRA 46 Stem Cell Research ISSCR 46 Tiotropium 46 platelet reactivity 46 Chemophase 46 posaconazole 46 Benign Prostatic Hyperplasia BPH 46 Bichat Claude Bernard 46 phase IIa clinical 46 timepoints 46 osteoporotic vertebral fractures 46 Haemostasis 46 Val HeFT 46 #nd EORTC NCI 46 WOMAC 46 fasting plasma glucose FPG 46 postherpetic neuralgia PHN 46 Diabetic Macular Edema DME 46 nonfasting triglyceride levels 46 Cambridge Healthtech Institute 46 Hormone Refractory Prostate Cancer 46 pan HDAC inhibitor 46 PEGylated interferon beta 1a 46 meta analyzes 46 achieved statistical significance 46 systolic hypertension 46 Female Urology 46 International Cartilage Repair 46 PHPT 46 Retina Specialists ASRS 46 Kidney Int 46 Minimally Invasive Gynecology 46 Ann Intern Med 46 CHEST 46 dual endothelin receptor antagonist 46 Lancet Neurology 46 Microplasmin 46 annual Transcatheter Cardiovascular 46 Bone Mineral Density 46 Hypercholesterolemia 46 evaluating REVLIMID 46 bortezomib refractory 46 Clinical Neurophysiology 46 vildagliptin 46 Cell Transplant 46 Int J Epidemiol 46 BARACLUDE ® 46 landmark ATHENA trial 46 preoperatively 46 Cimzia TM 46 MADIT CRT 46 Infectious Diseases Society 46 ruboxistaurin 46 Urocortin 2 46 ACEI 46 Cancer EORTC 46 Nesiritide 46 Acute Ischemic Stroke 46 DDW ® 46 sirolimus stent 46 claudication 46 MASCC 46 monotherapy 46 journal Menopause 46 ACR ARHP Annual 46 CTRC AACR 46 CAMMS# 46 Psychopharmacology 46 NYHA functional class 46 pegylated interferon alfa 2b 46 CALGB 46 crizotinib PF # 46 Bladder Cancer 46 AVADO 46 multicenter prospective 46 sunitinib malate 46 Pegasys ® 46 infliximab 46 Paroxysmal Nocturnal Hemoglobinuria PNH 46 Randomized Double blind 46 Zenvia Phase III 46 clinicopathological 46 LibiGel ® 46 timepoint 46 HBeAg negative patients 46 Certican 46 primary efficacy endpoints 46 Vaccine Immunology 46 Retroviruses 46 EuroIntervention 46 advanced hepatocellular carcinoma 46 multicenter trials 46 Heart Failure Therapies 46 Pharmaceutical Scientists AAPS 46 evaluable patients 46 KRN# 46 Nat Genet 46 Pediatric Academic Society 46 Cochrane Database 46 University Hospital Gasthuisberg 46 alteplase 46 Geriatric Society 46 TLR antagonists 46 Score DAS 46 Gynecol Oncol 46 Spine Arthroplasty Society 46 QVAR ® 46 CR# vcMMAE 46 Vulnerable Plaque 46 MGd 46 Breast Cancer Symposium SABCS 46 #:#-# [031] 46 NATRECOR ® 46 Lysosomal Disease Network 46 Dr. McHutchison 46 assessing T DM1 46 LymphoStat B 46 NNT = 46 Gastroenterology ACG 46 mcg dose 46 RE LY 46 Acute Heart Failure 46 Decitabine 46 Endovascular Therapy 46 CYPHER R Sirolimus eluting 46 FOCIS 46 spondyloarthritis 46 Timed Walk 46 Cholesterol Levels SPARCL 46 APOPTONE 46 Zemplar Capsules 46 RhuDex 46 Drugs Affecting Lipid 46 Metastatic Melanoma 46 Diabetes EASD Annual Meeting 46 Xelox 46 Secondary endpoints 46 CALGB # [002] 46 Venous Forum 46 antihypertensive therapy 46 macroalbuminuria 46 Endocrine Society Annual Meeting 46 fondaparinux 46 acute gout 46 Neurochemistry 46 overactive bladder symptoms 46 Cancer Incidence Mortality 46 Lung Transplantation ISHLT 46 odanacatib 46 Lung Cancer IASLC 46 Zarnestra 46 AFib 46 8mg/kg 45 histone deacetylase HDAC inhibitor 45 Evaluation WISE 45 Neurosurgery Spine 45 STRIDE PD 45 Quinamed 45 MAGE A3 ASCI 45 www.hematology.org 45 Removab 45 EURIDIS 45 Breast Surgeons 45 Genital Infection 45 prospectively defined 45 Score TOS 45 Nat Med 45 analgesic efficacy 45 HFSA Annual 45 ARCALYST ® 45 GAMMAGARD 45 HER2 expression 45 GTCbio 45 tipranavir ritonavir 45 Chronic Lymphocytic Leukemia CLL 45 Pain IASP 45 Solorel TM 45 recurrent malignant glioma 45 Secondary endpoints include 45 Endoscopic Surgeons SAGES 45 certolizumab 45 RECORD1 45 carotid stenosis 45 oral prodrug 45 standard chemotherapy regimen 45 fluticasone salmeterol 45 www.nejm.org 45 ustekinumab 45 Scale EDSS 45 NICE SUGAR 45 serologically active patients 45 Onrigin 45 RE LY trial 45 candesartan cilexetil 45 Annual BIO 45 Visual Analogue Scale VAS 45 opioid induced bowel dysfunction 45 pertuzumab 45 rufinamide 45 Severity MSCS score 45 ALLHAT 45 Experimental Neurology 45 randomized discontinuation trial 45 NAEPP 45 fibromyalgia syndrome 45 QTc 45 Hospital Clinico San 45 antithrombotic therapy 45 Torisel 45 cardiovascular morbidity 45 metaglidasen 45 Prediabetes 45 recurrent DVT 45 retinal vein occlusion 45 oral Xeloda 45 Refractory Angina 45 Amrubicin 45 Investigative Dermatology 45 antiangiogenic therapy 45 SHPT 45 multicenter study 45 Gynecological Cancer 45 journal Ophthalmology 45 BARI 2D 45 Restless Legs Syndrome 45 J Clin Invest 45 CYT# potent vascular disrupting 45 INCB# [002] 45 clinically meaningful improvement 45 ASCO Gastrointestinal Cancers Symposium 45 depsipeptide 45 Cancer Immunotherapy 45 idraparinux 45 attention-deficit/hyperactivity disorder ADHD 45 Gynecologic Oncologists 45 substudy 45 venous thromboembolic disease 45 FOLOTYN ® 45 See CLINICAL PHARMACOLOGY 45 fosbretabulin 45 OAB symptoms 45 VEITHsymposium 45 chromium supplementation 45 enzastaurin 45 Pulmonary Arterial Hypertension 45 Clinical Chemistry AACC 45 Azedra 45 non valvular atrial 45 Ophthalmic Drugs Advisory 45 LD Micro 45 Healthcare Epidemiology 45 Arrhythmias 45 TAXUS ATLAS 45 ASCO abstract 45 virologic response 45 atherothrombosis 45 MERIT ES 45 Sprycel dasatinib 45 Taxotere ® 45 chronic rhinosinusitis CRS 45 Myelodysplastic Syndromes 45 Cardiometabolic Risk 45 Pulmonary Hypertension 45 azacitidine 45 AAO HNSF 45 non fasting triglycerides 45 worsening thrombocytopenia 45 EMBO J. 45 vitamin D inadequacy 45 Virologic 45 CORD II 45 tipranavir r 45 Clinical Pharmacology 45 myocardial ischemia 45 Clinical Practice Guidelines 45 PAOD 45 ASTMH 45 mCRC patients 45 Hopital Pitie Salpetriere 45 Prostate AdenoCarcinoma Treatment 45 hemoglobin A1c levels 45 Trandolapril 45 TASKi2 45 tiotropium 45 Clinical Gastroenterology 45 Aryplase 45 angiographic outcomes 45 Secondary efficacy endpoints 45 HIV HCV coinfected 45 Atypical Hemolytic Uremic Syndrome 45 rFVIIa 45 Gastroenterology Week UEGW 45 Multicenter 45 Antimicrobial Chemotherapy 45 Thoracic Surgeons 45 Neovascular AMD 45 Neurology 45 Juvenile Idiopathic Arthritis 45 SEROQUEL 45 abacavir lamivudine 45 ASMBS 45 JAMA. 45 elotuzumab 45 Skin sterol 45 Viral Hepatitis 45 patients evaluable 45 Asthma Allergy 45 subtrochanteric 45 IFN beta 45 SCAI Annual 45 DASISION 45 PKC# 45 CIBMTR 45 socioeconomic gradient 45 American Roentgen Ray 45 metastatic hormone refractory 45 Medicine SIIM 45 TRANSFORMS 45 neoadjuvant treatment 45 Society ILADS 45 Celsentri Selzentry 45 Clinical Endocrinology 45 eosinophilic asthma 45 Clinical Dermatology 45 Therapeutic Advances 45 Cardiovascular Angiography 45 ERSPC 45 Interventional Radiology 45 glatiramer acetate 45 Neoplasia 45 GASTRO 45 palifosfamide 45 Clavis Pharma 45 Pharmacoeconomic 45 HQK 45 microbiological eradication 45 Intensive Care Medicine 45 ENESTnd 45 ZFP Therapeutic 45 Bazedoxifene 45 Non Alcoholic Fatty 45 TNF alpha inhibitor 45 thromboprophylaxis 45 Clinical Psychopharmacology 45 acetabular dysplasia 45 Physiological Therapeutics 45 belimumab 45 achieved CCyR 45 IJCP 45 Diabet Med 45 number NCT# ClinicalTrials.gov 45 lipid parameters 45 Oral Presentations 45 MEND CABG II 45 Spine Society 45 diabetes dyslipidemia 45 OXi# 45 MEND CABG 45 diabetic gastroparesis 45 CR nPR 45 invasive aspergillosis 45 Rate ORR